News - Advair, Menarini


Current filters:


Popular Filters

Menarini inaugurates its China headquarters in Wuhan Biolake

Menarini inaugurates its China headquarters in Wuhan Biolake


Family-owned Menarini Group, Italy’s largest biopharma company, has officially launched its China headquarters…


Analysts recommend GSK after Teva announces Advair generic delay

Analysts recommend GSK after Teva announces Advair generic delay


The delay for the generic version of GlaxoSmithKline’s Advair coupled with the advances in the company’s…

AdvairdarapladibEuropeFinancialGlaxoSmithKlineNeurologicalPharmaceuticalRespiratory and PulmonaryTeva Pharmaceutical Industries

Vivus partners with Menarini for European and Australia/NZ marketing of ED drug


US drugmaker Vivus (Nasdaq: VVUS) has entered into a license and commercialization agreement and a supply…

Asia-PacificavanafilEuropeLicensingMarkets & MarketingMen's HealthMenariniPharmaceuticalReproductiveSpedraVivus

Great expectations for GlaxoSmithKline R&D newsflow


Essentially, analysts at Panmure Gordon & Co anticipate a lot of pipeline newsflow from UK pharma giant…


Asthma preventive drugs market led by GlaxoSmithKline's Advair


The asthma preventive drugs market has been forecast to increase at a compound annual growth rate (CAGR)…

AdvairAstraZenecaGlaxoSmithKlineMarkets & MarketingMerck & CoPharmaceuticalRespiratory and PulmonarySingulairSymbicort

Menarini in $1 billion partnership with Oxford BioTherapeutics for cancer drug development


In a second major deal within just over a year for the UK-based antibody-based drug developer, BioTherapeutics…

BiotechnologyLicensingMenariniOncologyOxford BioTherapeuticsPharmaceuticalResearch

Almirall out-licenses aclidinium to Invida for Australia and New Zealand


Leading Spanish drugmaker Almirall (ALM: MC) has granted Singapore-based Invida, a member of the Italian…

aclidiniumAlmirallAsia-PacificInvidaLicensingMenariniPharmaceuticalRespiratory and Pulmonary

New LABA/LAMA drugs set to fracture COPD market


The drug market for chronic obstructive pulmonary disease (COPD) therapies will become more fractured…

AdvairBoehringer IngelheimGlaxoSmithKlineGlobalMarkets & MarketingPfizerPharmaceuticalRespiratory and PulmonarySpiriva

Almirall's aclidinium approved in Europe for COPD maintenance treatment


Spain's leading drugmaker, Almirall (ALM: MC) says that the European Commission has granted marketing…

aclidiniumAlmirallBretaris GenuairEklira GenuairEuropeMenariniPharmaceuticalRegulationRespiratory and Pulmonary

Novo Nordisk and AstraZeneca among firms to invest in Russian pharma hub


In Russia, the Kaluga government plans to establish a pharmaceutical manufacturing hub in the region…

AstraZenecaEuropeFinancialMarkets & MarketingMenariniNovo NordiskPharmaceuticalSTADA Arzneimittel

Furiex Pharma gets rights to Priligy, some of which it sells on to Menarini


In a two part transaction, USA-based Furiex Pharmaceuticals (Nasdaq: FURX) has entered into an agreement…

ALZA CorpFuriex PharmaceuticalsJanssen PharmaceuticaJohnson & JohnsonLicensingMen's HealthMenariniPharmaceuticalPriligy

Faes Farma and Menarini unit link to commercialize bilastine in Asia-Pacific


Spanish drugmaker Faes Farma (FAE: SM) and Invida Holding, part of family owned Italian drugmaker Menarini,…

Asia-PacificbilastineFaes FarmaInvidaLicensingMenariniPharmaceuticalRespiratory and Pulmonary

Menarini extends febuxostat accord to more regions


Japanese drugmaker Teijin Pharma and privately-owned Italian pharmaceutical company Menarini have signed…


Relovair COPD and asthma filings on track despite more mixed trial results


As well as announcing new mixed clinical trial data, UK pharma giant GlaxoSmithKline (LSE: GSK) and US…

AdvairEuropeGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationRelovairRespiratory and PulmonaryTheravance

Italy’s Menarini takes giant step into Asia-Pacific, with acquisition of Invida


Italy’s leading independent drugmaker Menarini says it has acquired the Singapore-based Invida Group,…

Asia-PacificInvidaMenariniMergers & AcquisitionsPharmaceutical

Menarini succession plan sees Aleotti offspring take over


Due to health reasons, Alberto Aleotti, the president of Italian family-owned drugmaker Menarini, has…


Menarini strongly denies it is looking to sell or list on stock exchange


Family-owned Italian drugmaker Menarini categorically denies that it has given any kind of mandate to…

FinancialMenariniMergers & AcquisitionsPharmaceutical

Back to top